Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

Clinical trial NCT07702032 · RECRUITING

Trial details

NCT number: NCT07702032
Sponsor: Genmab
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Left-sided Colorectal Cancer

Start date: 2026-08-11
Primary completion: 2029-07-01
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.